US approves ‘breakthough’ gene therapy for leukaemia – South China Morning Post
South China Morning Post |
US approves 'breakthough' gene therapy for leukaemia
South China Morning Post The US approved the first gene therapy against cancer on Wednesday – a treatment that uses a patient's own immune cells to fight leukaemia – opening a new era in the fight against one of the world's top killers. The treatment is made by Novartis and is … FDA Approves Groundbreaking Gene Therapy for Cancer FDA approval brings first gene therapy to the United States FDA Approves First Gene Therapy For Leukemia |
